ZFAND6 regulation of innate antiviral immunity
ZFAND6 对先天抗病毒免疫的调节
基本信息
- 批准号:9979076
- 负责人:
- 金额:$ 23.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-16 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:A20 proteinAddressAgonistAntiviral AgentsAutomobile DrivingBindingBiologicalBone MarrowC-terminalCachexiaCellsDNADNA VirusesDevelopmentDoseDown-RegulationEnzymesFamilyFamily memberFeedbackFibroblastsFoundationsFrequenciesGene TargetingGenesHerpesvirus 1HomeostasisHuman GenomeIRF1 geneIRF3 geneImmuneImmune signalingInfectionInflammationInflammatoryInflammatory ResponseInfluenza A virusInnate Immune ResponseInterferon Type IInterferonsInvestigationKnockout MiceKnowledgeLinkLungLung InflammationLysineMediatingMolecularMorbidity - disease rateMusN-terminalNatural ImmunityNucleic AcidsPRKCA genePathogenicityPathway interactionsPatternPattern recognition receptorPhosphotransferasesPhysiologicalPlantsPlayPolyubiquitinProteinsPublishingPulmonary InflammationRNARNA VirusesRegulationReporterResistanceRoleSequence HomologySignal PathwaySignal TransductionSignaling ProteinSpleenStainsStimulusStress-Induced ProteinTissuesToll-like receptorsTransferaseUbiquitinVesicular stomatitis Indiana virusViralViral Load resultVirusVirus DiseasesWild Type MouseZinc Fingersantiviral immunitycell typechemokinecytokineexperimental studyfitnessgene inductiongut microbiotahelicaseimmune activationimmunopathologyinsightmacrophagemortalitynovel therapeuticsovarian neoplasmoverexpressionpathogenpathogenic viruspreventprotein degradationprotein functionreconstitutionrepairedresponsestress tolerancetranscription factortranscriptome sequencingviral DNA
项目摘要
ABSTRACT
The A20 ubiquitin-editing enzyme is a key negative regulator of NF-κB and innate immune signaling pathways.
A20 contains seven zinc finger (ZF1-7) domains, of which ZF4 interacts with lysine 63 (K63)-linked
polyubiquitin chains to suppress NF-κB signaling. Including A20, there are 10 genes containing A20 ZF
domains encoded in the human genome; however, with the exception of A20 the functions of these proteins
are poorly understood. ZFAND6 (also known as AWP1) contains an A20-like ZF domain that shares significant
sequence homology with A20 ZF4, and also harbors an AN1-type ZF. Although published overexpression
studies suggest that ZFAND6 may inhibit NF-κB, the specific pathways regulated by ZFAND6 and its
physiological roles have remained elusive. In preliminary studies for this exploratory proposal, we have used
gene targeting to generate mice lacking the Zfand6 gene. Zfand6–/– mice are born at expected Mendelian
frequencies with no obvious developmental or immune abnormalities. RNA sequencing of Zfand6–/– bone
marrow-derived macrophages revealed spontaneous induction of interferon-stimulated genes (ISGs), which
rendered these cells highly resistant to infection with a broad range of DNA and RNA viruses. The DNA
sensing pathway adaptor STING and the antiviral transcription factor IRF1 were both upregulated in Zfand6–/–
cells, which may drive the resistance of ZFAND6-deficient cells to virus infection. ISGs were upregulated in the
spleen, but not in the lungs, of Zfand6–/– mice, and knockout mice were more susceptible than wild-type mice
to mortality upon challenge with a low dose of influenza A virus (IAV) despite comparable viral loads.
Therefore, loss of ZFAND6 may perturb immune homeostasis and exacerbate virus-induced inflammation and
immunopathology. The central hypothesis driving these investigations is that ZFAND6 targets key innate
immune signaling proteins for degradation to prevent the spontaneous induction of ISGs which may contribute
to overexuberant inflammation triggered by virus infection. To address this hypothesis we will perform the
following Specific Aims: 1) Determine the mechanisms of ZFAND6 inhibition of antiviral signaling, and 2)
Determine the role of ZFAND6 in regulating the inflammatory response to IAV infection. Completion of these
studies will define a physiological role for ZFAND6 in restricting innate antiviral immunity and expand our
knowledge on the mechanisms of immune homeostasis which serve to mitigate virus-induced inflammation.
摘要
A20泛素编辑酶是核因子-κB和天然免疫信号通路的关键负调控因子。
A20含有7个锌指(ZF1-7)结构域,其中ZF4与赖氨酸63(K63)连接
抑制NF-κB信号转导的多泛素链。包括A20在内,有10个基因含有A20 ZF
人类基因组中编码的结构域;然而,除了A20以外,这些蛋白质的功能
人们对此了解甚少。ZFAND6(也称为AWP1)包含一个类似A20的ZF结构域,它具有重要的
与A20ZF4序列同源性,也含有AN1型ZF。虽然发表了过度表达
研究表明,ZFAND6可能抑制NF-κB,这是ZFAND6及其受体调控的特定信号通路。
生理角色仍然难以捉摸。在对这一探索性建议的初步研究中,我们使用了
基因打靶以产生缺乏Zfand6基因的小鼠。Zfand6-/-小鼠在预期的孟德尔出生
无明显发育或免疫异常的频率。Zfand6-/-骨的RNA测序
骨髓来源的巨噬细胞显示自发诱导干扰素刺激基因(ISGs),这是
使这些细胞对广泛的DNA和RNA病毒感染具有高度抵抗力。DNA
感觉通路接头刺痛和抗病毒转录因子IRF1在Zfand6-/-中均上调
细胞,这可能驱动ZFAND6缺陷细胞对病毒感染的抵抗力。ISG在
Zfand6-/-小鼠和基因敲除小鼠比野生型小鼠更易患脾,但不在肺
与低剂量甲型流感病毒(IAV)攻击时的死亡率,尽管病毒载量相当。
因此,ZFAND6的缺失可能会扰乱免疫稳态,加剧病毒诱导的炎症和
免疫病理学。推动这些研究的中心假设是ZFAND6针对关键的先天
免疫信号蛋白的降解,以防止自发诱导的ISG,这可能有助于
病毒感染引发的过度炎症。为了解决这一假设,我们将执行
具体目标如下:1)确定ZFAND6抑制抗病毒信号的机制;2)
确定ZFAND6在调节IAV感染的炎症反应中的作用。完成这些工作
研究将确定ZFAND6在限制先天抗病毒免疫中的生理作用,并扩大我们的
了解免疫动态平衡的机制,以减轻病毒引起的炎症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD W HARHAJ其他文献
EDWARD W HARHAJ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD W HARHAJ', 18)}}的其他基金
KDR/VEGFR2 regulation of HTLV-1 oncogenesis and viral gene expression
KDR/VEGFR2 对 HTLV-1 肿瘤发生和病毒基因表达的调节
- 批准号:
10610829 - 财政年份:2022
- 资助金额:
$ 23.75万 - 项目类别:
KDR/VEGFR2 regulation of HTLV-1 oncogenesis and viral gene expression
KDR/VEGFR2 对 HTLV-1 肿瘤发生和病毒基因表达的调节
- 批准号:
10353507 - 财政年份:2022
- 资助金额:
$ 23.75万 - 项目类别:
AIP inhibition of IRF7 and innate antiviral signaling
AIP 抑制 IRF7 和先天抗病毒信号
- 批准号:
10217831 - 财政年份:2021
- 资助金额:
$ 23.75万 - 项目类别:
Negative regulation of innate immune signaling pathways by the selective autophagy receptor TAX1BP1
选择性自噬受体 TAX1BP1 对先天免疫信号通路的负调节
- 批准号:
10276931 - 财政年份:2021
- 资助金额:
$ 23.75万 - 项目类别:
Negative regulation of innate immune signaling pathways by the selective autophagy receptor TAX1BP1
选择性自噬受体 TAX1BP1 对先天免疫信号通路的负调节
- 批准号:
10797470 - 财政年份:2021
- 资助金额:
$ 23.75万 - 项目类别:
Negative regulation of innate immune signaling pathways by the selective autophagy receptor TAX1BP1
选择性自噬受体 TAX1BP1 对先天免疫信号通路的负调节
- 批准号:
10622514 - 财政年份:2021
- 资助金额:
$ 23.75万 - 项目类别:
AIP inhibition of IRF7 and innate antiviral signaling
AIP 抑制 IRF7 和先天抗病毒信号
- 批准号:
10393620 - 财政年份:2021
- 资助金额:
$ 23.75万 - 项目类别:
Negative regulation of innate immune signaling pathways by the selective autophagy receptor TAX1BP1
选择性自噬受体 TAX1BP1 对先天免疫信号通路的负调节
- 批准号:
10414107 - 财政年份:2021
- 资助金额:
$ 23.75万 - 项目类别:
The role of TAX1BP1 in the innate immune response to virus infection
TAX1BP1在病毒感染先天免疫反应中的作用
- 批准号:
8998913 - 财政年份:2015
- 资助金额:
$ 23.75万 - 项目类别:
Mechanisms of HTLV-I Tax-mediated NF-kB activation
HTLV-I Tax 介导的 NF-kB 激活机制
- 批准号:
8210991 - 财政年份:2009
- 资助金额:
$ 23.75万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 23.75万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 23.75万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 23.75万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 23.75万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 23.75万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 23.75万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 23.75万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 23.75万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 23.75万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 23.75万 - 项目类别:
Research Grant